Human Interleukin 27,IL-27 ELISA Kit

Code CSB-E08464h
Size 96T,5×96T,10×96T
Price Request a Quote or Start an on-line Chat
Trial Size 24T ELISA Kit Trial Size (Only USD$150/ kit)
* The sample kit cost can be deducted from your subsequent orders of 96T full size kits of the same analyte at 1/5 per kit, until depleted in 6 months. Apply now

Product Details

Alternative Names
EBI3 ELISA Kit; IL 27 ELISA Kit; IL 27 p28 subunit ELISA Kit; IL 27A ELISA Kit; IL 30 ELISA Kit; IL-27 subunit alpha ELISA Kit; IL-27-A ELISA Kit; IL27 ELISA Kit; IL27-A ELISA Kit; IL27A ELISA Kit; IL27A_HUMAN ELISA Kit; IL27p28 ELISA Kit; IL30 ELISA Kit; Interleukin 27 ELISA Kit; Interleukin 27 subunit alpha ELISA Kit; Interleukin 27; 28-KD subunit ELISA Kit; Interleukin 30 ELISA Kit; Interleukin-27 subunit alpha ELISA Kit; p28 ELISA Kit
Uniprot No.
Homo sapiens (Human)
Sample Types
serum, plasma, tissue homogenates
Detection Range
0.156 ng/ml - 10 ng/ml
0.039 ng/ml
Assay Time
Sample Volume
Detection Wavelength
450 nm
Research Area
Assay Principle
and FAQs
Store at 2-8°C. Please refer to protocol.
Lead Time
3-5 working days after you place the order, and it takes another 3-5 days for delivery via DHL or FedEx

This human IL-27 ELISA Kit is suitable for qualitatively determining human concentrations in multiple biological fluids, including human serum, plasma, and tissue homogenates in vitro.IL27 is a heterodimeric cytokine that plays a role both in innate and adaptive immunity. IL27 engages the IL27 receptor and then recruits several Jak family kinases, activating the JAK-STAT pathway, thus mediating many cellular processes, including cellular differentiation, proliferation, and immunologic responses. Studies have shown that IL27 regulates T cell responses that prevent immune hyperactivity, suggesting a possible therapeutic for chronic inflammatory conditions with excessive T cell activation, such as MS and rheumatoid arthritis. Contrastly, IL27 exerts pro-inflammatory functions by promoting the clonal expansion of naive CD4+ T-cells and the survival of Treg and CD8+ T cells and stimulating tumor-specific cytotoxic T cell responses.

This kit uses the quantitative sandwich-based enzyme immunoassay technique to measure the amount of human IL-27 in the sample. Standards and samples are respectively added to the microplate wells pre-coated with an anti-human IL-27 antibody. Biotin-labeled IL-27 antibody, HRP-avidin, and TMB substrate are pipped into the microplate in turn. The capture antibody pre-coated on the plate captures the IL-27 in the human samples. IL-27 binds to the biotinylated anti-IL-27 human monoclonal antibody. And the biotin on the biotinylated anti-IL-27 human monoclonal antibody binds to the avidin on the enzyme label, forming immune complexes. The color renders blue after the addition of the TMB substrate. The addition of the stop solution into the wells immediately turns the blue into yellow. The concentration of IL-27 in the samples is directly proportional to OD (450nm). Each manufactured lot of this ELISA kit was quality tested for criteria such as sensitivity, specificity, precision, linearity, and lot-to-lot consistency.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

(From Uniprot)
Associates with EBI3 to form the IL-27 interleukin, a heterodimeric cytokine which functions in innate immunity. IL-27 has pro- and anti-inflammatory properties, that can regulate T-helper cell development, suppress T-cell proliferation, stimulate cytotoxic T-cell activity, induce isotype switching in B-cells, and that has diverse effects on innate immune cells. Among its target cells are CD4 T-helper cells which can differentiate in type 1 effector cells (TH1), type 2 effector cells (TH2) and IL17 producing helper T-cells (TH17). It drives rapid clonal expansion of naive but not memory CD4 T-cells. It also strongly synergizes with IL-12 to trigger interferon-gamma/IFN-gamma production of naive CD4 T-cells, binds to the cytokine receptor WSX-1/TCCR which appears to be required but not sufficient for IL-27-mediated signal transduction. IL-27 potentiate the early phase of TH1 response and suppress TH2 and TH17 differentiation. It induces the differentiation of TH1 cells via two distinct pathways, p38 MAPK/TBX21- and ICAM1/ITGAL/ERK-dependent pathways. It also induces STAT1, STAT3, STAT4 and STAT5 phosphorylation and activates TBX21/T-Bet via STAT1 with resulting IL12RB2 up-regulation, an event crucial to TH1 cell commitment. It suppresses the expression of GATA3, the inhibitor TH1 cells development. In CD8 T-cells, it activates STATs as well as GZMB. IL-27 reveals to be a potent inhibitor of TH17 cell development and of IL-17 production. Indeed IL27 alone is also able to inhibit the production of IL17 by CD4 and CD8 T-cells. While IL-27 suppressed the development of proinflammatory Th17 cells via STAT1, it inhibits the development of anti-inflammatory inducible regulatory T-cells, iTreg, independently of STAT1. IL-27 has also an effect on cytokine production, it suppresses proinflammatory cytokine production such as IL2, IL4, IL5 and IL6 and activates suppressors of cytokine signaling such as SOCS1 and SOCS3. Apart from suppression of cytokine production, IL-27 also antagonizes the effects of some cytokines such as IL6 through direct effects on T-cells. Another important role of IL-27 is its antitumor activity as well as its antiangiogenic activity with activation of production of antiangiogenic chemokines such as IP-10/CXCL10 and MIG/CXCL9. In vein endothelial cells, it induces IRF1/interferon regulatory factor 1 and increase the expression of MHC class II transactivator/CIITA with resulting up-regulation of major histocompatibility complex class II. IL-27 also demonstrates antiviral activity with inhibitory properties on HIV-1 replication.
Gene References into Functions
  1. Over-expression of IL-17 and IL-27 are involved in the pathogenesis of liver damage in children with human cytomegalovrius infection. PMID: 30022757
  2. Interleukin-27 differentially regulates the expression of seven novel microRNAs. PMID: 29343703
  3. Patients with tuberculous pleural effusion have an about 26-fold higher chance of being IL-27 test-positive compared to patients with malignant pleural effusion. [meta-analysis] PMID: 29539604
  4. there was a significant increase in the risk of Kawasaki disease with coronary arterial lesions in children with the rs17855750 (T>G), rs40837 (A>G), rs4740 (G>A), rs4905 (A>G), rs153109 (T>C), and rs26528 (A>G) Single-nucleotide Polymorphisms. PMID: 29973303
  5. our results showed that SNP rs153109 displayed significant associations with dilated cardiomyopathy in Chinese Han population, whereas no differences in genotype or allele frequencies were found between dilated cardiomyopathy patients and controls at SNP rs17855750. PMID: 29754565
  6. Human Immunodeficiency virus type-1 myeloid derived suppressor cells inhibit cytomegalovirus inflammation through IL-27 and B7-H4. PMID: 28338007
  7. IL-27 enhances the potential of reactive oxygen species generation from monocyte-derived macrophages and dendritic cells by induction of p47(phox). PMID: 28240310
  8. IL-27 has a unique ability to directly act on hematopoietic stem cells and promote their expansion and differentiation into myeloid progenitors in hematologic neoplasms and malaria. (Review) PMID: 29218601
  9. IL-27 rs153109 and rs17855750 Polymorphisms are associated with Risk and Response to Therapy in Acute Lymphoblastic Leukemia. PMID: 28828696
  10. IL-27 was down-regulated in the malignant Middle Cerebral Artery Infarction. PMID: 28828208
  11. IL-27 may be involved in the development of coronary artery lesions in acute Kawasaki disease. PMID: 28108813
  12. Hepatitis B virus infection can lead to overexpression of interleukin-27 gene in liver transplant patients. PMID: 26925776
  13. this study indicates that IL-27 secreted by cervical carcinoma cells restricts the angiogenesis in a paracrine manner in the pathogenesis of cervical cancer PMID: 28508429
  14. IL-27 signaling (IL-27 and its receptor) may be involved in the pathogenesis of HIV infection and immune reconstitution in HIV/AIDS patients who underwent HAART. IL-27 may exert effects through regulating Th1 / Th2 ratio. PMID: 28521720
  15. This study provides additional evidence that IL-27 may contribute to autoimmune processes in MS patients. PMID: 28738904
  16. this study shows that IL-27 regulates the adherence, proliferation, and migration of placenta-derived mesenchymal stromal cells and enhances their regulatory effects on Th1 and Th2 subset generations PMID: 28612255
  17. This study failed to find an association between common variants in the functional region of IL27 and coronary artery disease in a Chinese Han population PMID: 27174010
  18. Data point out to a broad set of activities shared by IL-27 and IFN-gamma, which are dependent on the common activation of the STAT1 pathway. These data add further explanation to the anti-tumor activity of IL-27 and also to its dual role in immune regulation PMID: 27683036
  19. The current meta-analysis suggests that IL-27 -964A/G polymorphism might enhance cancer risk. However, large-scale and well-designed studies are still needed to confirm the result of our meta-analysis PMID: 25424605
  20. this study found elevated expression of IL-27 in human peripheral serum and elevated expression of its specific receptor (wsx-1) on fetal membranes in cases of preterm birth PMID: 28756371
  21. results indicate that elevated IL-27 strongly correlates with EOS and may provide additional diagnostic value along with PCT. PMID: 27648693
  22. serum interleukin-27 and interleukin-35 concentrations in patients with Guillain-Barre syndrome PMID: 28167198
  23. Expression of IL-27 in the serum was markedly increased in patients with sepsis-induced myocardial dysfunction compared with that in controls. PMID: 27525353
  24. IL-27 significantly inhibited the M2 macrophages polarization and dampened the proliferation, migration and metastasis of pancreatic cancer cells and as well enhanced the efficacy of gemcitabine. PMID: 26868086
  25. IL-27 increased NLRP3 inflammasome activation in monocytes with enhanced release of IL-1 beta. PMID: 29176764
  26. this study shows that interleukin 27 is up-regulated in patients with active inflammatory bowel disease PMID: 27221243
  27. IL-27 polymorphisms might play a protective role for the development of ulcerative colitis in the Mexican population PMID: 26905929
  28. IL-27 stimulation activated STAT1 and STAT3 in HeLa and T98G cells, suggesting that IL-27 engages the STAT1/3 pathway, which then leads to the upregulation of IL-6, IP-10, and MIG PMID: 27617644
  29. IL-27 and IL-37 limit the induction of particular T cell subsets along with cytokine responses in S. stercoralis infections, which suggest the importance of IL-27 and IL-37 in immune modulation in a chronic helminth infection. PMID: 28874444
  30. IL-27 is a pivotal regulator in endometriotic immune tolerance by triggering Th17 cells to produce IL-10. PMID: 28300844
  31. Significantly increased papillary thyroid carcinoma risk was also associated with rs17855750 GT and GT/GG genotypes. PMID: 27929666
  32. HIV and Tat inhibit LPS-induced IL-27 production in human macrophages via distinct mechanisms: Tat through the inhibition of cIAP-1-TRAF-6 and subsequent inhibition of PI3K and p38 MAPKs, whereas HIV through the inhibition of p38 MAPK activation. PMID: 28698313
  33. IL27 recapitulates IFN-gamma responses in hepatocellular carcinoma cells, but is inhibited by IL6-type cytokines. PMID: 27939431
  34. These findings provide new evidence that IL-27 plays an important role in the proinflammatory capacity of monocytes and macrophages via enhancing IL-1beta secretion levels triggered by dual LPS-ATP stimulation. PMID: 28377398
  35. IL-27 enhanced the cytotoxicity and suppressed the proliferation of ovarian cancer cells PMID: 27639718
  36. the sIL-6R/p28 fusion protein (FP) upregulated IFN-lambda1 expression by increasing the binding abilities of c-Fos and activating transcription factor 1 to the IFN-lambda1 promoter via the p38 MAPK signaling pathway; results demonstrate the important role of sIL-6R/p28 FP in mediating virus-induced type III IFN production. PMID: 27527594
  37. These results identify IL-27 and its specific receptor IL27RA as a critical immune axis for the antiviral immune response and as robust correlates of viral load and proviral reservoir size in mononuclear leukocytes in HIV infection. PMID: 28592538
  38. IL30 regulates breast cancer cell viability, migration, and gene expression to promote breast cancer growth and progression and its impact on patient outcome. PMID: 27550449
  39. serum IL-27 levels were significantly higher in stage III EV71-infected hand, foot, and mouth disease patients with early cardiopulmonary failure and strong correlation with CRP levels; IL27p28 polymorphisms (rs153109, rs17855750, and rs181206) did not influence IL-27 production, and these three SNPs were not associated with EV71 infection risk and clinical stage PMID: 27403033
  40. these results suggest that IL-27 might predominantly play a protective role in the pathogenesis of psoriasis through abrogating Th17 differentiation. PMID: 27939414
  41. our data suggest a previously unrecognized role for IL-27 in regulating epithelial cell proliferation and antiviral host defense during the normal wound healing response. PMID: 28132857
  42. An association between the IL-27 single nucleotide polymorphism (SNP) rs153109 and Atrial Fibrillation was found in Chinese Han population. The G allele and GG genotype of rs153109 were associated with increased AF risk (odds ratio [OR]: 1.35, 95% confidence intervals [CI]=1.06-1.71, p=0.02 and OR: 1.66, 95% CI=1.03-2.65, p=0.03 in the recessive genetic model, respectively) PMID: 28055231
  43. Study demonstrated that levels of circulating serum IL-27 were elevated in rheumatoid arthritis (RA) patients and were positively correlated with RA disease activity. Moreover, these concentrations decreased after effective immunosuppressant treatment suggesting its involvement in the pathogenesis of RA. PMID: 27869736
  44. Data indicate that the genetic variant rs153109 in the 5' upstream region of interleukin 27 (IL-27) is significantly associated with ulcerative colitis (UC) in Chinese Han individuals. PMID: 28069403
  45. this study shows that the serum levels of IL-27 are lower in Iranian diabetes type I patients compared to the healthy individuals PMID: 27611173
  46. our findings showed a relationship between the IL-27 2905T/G genotype variant and the decreased susceptibility for developing cervical cancer. The IL-27 2905T/G genotype variant also modified the survival time in cervical cancer patients. PMID: 26662568
  47. an IL-27/Stat3 axis induces expression of programmed cell death 1 ligands (PD-L1/2) on infiltrating macrophages in lymphoma PMID: 27564404
  48. Interleukin-27 rs 153109 Single Nucleotide Polymorphism is associated with responses to therapy in Hepatitis C. PMID: 27221901
  49. this study shows that IL-27 gene polymorphism is genetic risk factor for systemic lupus erythematosus in the Polish population, and that it predicts disease phenotype PMID: 27059274
  50. Data indicate that the CC genotype of interleukin 27 (IL-27) single nucleotide polymorphism rs153109 was significantly more prevalent in pre-eclampsia (PE) cases than controls. PMID: 26971578

Show More

Hide All

Subcellular Location
Secreted. Note=Does not seem to be secreted without coexpression of EBI3.
Protein Families
IL-6 superfamily
Tissue Specificity
Expressed in monocytes and in placenta.
Database Links

HGNC: 19157

OMIM: 608273

KEGG: hsa:246778

STRING: 9606.ENSP00000349365

UniGene: Hs.528111

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
7505 Fannin St., Ste 610, Room 322 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join Us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2023 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1